ABSTRACT OBJECTIVE: Prolongation of the third stage of labor may cause serious postpartum complications. Thus, timely expulsion of the placenta is essential for preventing complications of the third stage of labor. We conducted a prospective cohort study to determine the effect of placental cord drainage on the duration of the TSL in women administered intravenous oxytocin during this stage.
Introduction
The third stage of labor (TSL) is defined as the time interval between delivery of the baby and the expulsion of the placenta. After delivery of the baby, health care providers usually give attention to the newborn. But this stage is also important for the woman who gave birth. Prolongation of the TSL leads to an increased likelihood of maternal morbidity and mortality and TSL-related complications, which include uterine atony, retained placenta, postpartum hemorrhage (PPH), hemorrhagic shock, and even maternal death (1, 2) . Reported childbirth-related maternal mortality is approximately 250.000 and 300.000 in the world annually (3) . The majorities of these mortalities are caused by complications during the TSL, and most commonly are from uterine atony and PPH (3) . The timely expulsion of the placenta and an efficient uterine contraction to cease bleeding are important parts of the TSL in preventing complications. Placental delivery is essential in allowing the uterus to contract and decrease blood loss during the TSL. Placental expulsion depends on the separation of the placenta from the uterine wall, capillary hemorrhage, uterine muscle contractile ability after placental separation, maternal effort, and gravity of the placenta (4, 5) . Separation of the placenta from the uterine wall is usually completed within 15 minutes in 90% of women after a fetal delivery (2, 6) . Prolongation of the TSL increases the development of PPH, which is responsible for one quarter of maternal deaths globally, one third of all pregnancy-related deaths in Africa and Asia, and approximately 140.000 deaths annually (7, 8) .
Preventive measures to decrease complications from the TSL are recommended for all women undergoing childbirth (9) . Interventions to prevent TSL complications are called active management of the third stage of labor (AMTSL). These interventions include early umbilical cord clamping, administration of an oxytocic agent, and controlled cord traction until delivery of the placenta (3, 8) . Placental cord drainage is also considered as an AMTSL method. Placental cord drainage facilitates placental delivery in both vaginal and cesarean section deliveries (10, 11) . Releasing the maternal side of the cord clamp and allowing the drainage of placental blood has been recommended by many obstetricians to facilitate the delivery of the placenta in vaginal deliveries (11) .
We conducted this prospective cohort trial to determine whether placental cord drainage would shorten the TSL duration in low-risk pregnant women receiving 20 IU oxytocin in 500 mL Ringer's Lactate (RL) intravenous (IV) infusion within 2 hours.
Material and Method
This study was undertaken between 1 February and 30 June 2010 in the obstetric unit of our hospital. The study was approved by the Institutional Ethics Committee and performed in accordance with the Helsinki Declaration (Institutional ethical approval no: 19/04/2010/6).
On admission to the labor room, a detailed history, vaginal examination, and blood count estimation were carried out with all patients. Eligible patients were informed about the study and written informed consent was obtained from each patient. A total of 112 women who had a vaginal delivery completed the trial. There were 53 (47.3%) women in the study group and 59 (52.6%) in the control group. Inclusion criteria were singleton cephalic presentation pregnancies, patients willing to give written informed consent and pregnancies between 37 and 42 weeks of gestational age. Exclusion criteria were intrauterine fetal demise, antepartum hemorrhage, malpresentation, hypertensive disorders, history of medical disorders, multiple pregnancy, chorioamnionitis, and coagulation abnormalities. Fetal and maternal monitoring during the first and second stages of labor were carried out. In cases where augmentation or induction of labor was indicated, an oxytocin infusion protocol was applied.
When the cervix was dilated to 10 cm and the fetus arrived at the perineum, the pregnant woman was transferred to the delivery ward. Following delivery of the neonate, the umbilical cord was clamped with two clamps, cut between the clamps, and the neonate was handed to the nurse who was educated for neonatal care. In the placental cord drainage group, after the cord was clamped and cut, immediate unclamping was performed on the maternal side of the cord and the blood in the placenta was allowed to drain freely. In the control group, the umbilical cord remained clamped until placental delivery. Immediately after fetal delivery, intravenous infusion of 20 IU oxytocin in 500 mL RL was started and transfused within 2 hours for women in both groups. Upon observing signs of placental separation (gush of blood from the vagina, descent of the umbilical cord, and an increase in the height of the uterus in the abdomen as the lower segment distends) and once the placenta came into the vagina, it was pulled out. The duration of the TSL was determined with a watch controlled by the same physician. Complete removal of the placenta and membranes was then confirmed. Any adverse event such as a prolonged third stage, a retained placenta, uterine atony, postpartum hemorrhage, and any vaginal tear was noted. If the placenta was not delivered after 30 minutes, it was considered a retained placenta. After completion of the TSL, the woman was transferred to the recovery room. Maternal pulse, blood pressure, and temperature were recorded within 15 minutes in the first hour and then hourly for the following six hours. At the postpartum sixth hour, a blood sample was taken to evaluate maternal hemoglobin levels.
All statistical analyses were performed using the Statistical Package for Social Sciences software, version 15.5 (SPSS, Chicago, IL, USA). Student's t-test and Mann-Whitney U test were used for statistical analyses. Parametric test results are presented as mean ± standard deviation; nonparametric test results are presented as a median with minimum and maximum values. The probability of the null hypothesis was set to a 0.05 value. From a total of 112 women, data were analyzed from 53 women in the placental drainage with oxytocin group and from 59 women in the oxytocin alone group.
Results
Demographic characteristics of the women in the two groups were similar with regard to age, body mass index (BMI), gravidity, parity, weeks of gestation, and fetal birth weight; thus, these results demonstrate that the groups were similar to each other and comparable (Table 1 ). There was no significant difference between the groups with regard to the duration of the first and second stages of labor with p values of 0.226 and 0.105, respectively. However, the duration of the TSL was significantly shorter in the placenta drainage group than in the oxytocin alone group (p <0.01) ( Table 2 ). In the oxytocin alone group, there was a single placental retention that was extracted with manual intervention under general anesthesia.
Discussion
The present study demonstrated that placental cord drainage shortens the duration of the third stage of labor in women who were administered an intravenous infusion of 20 IU oxytocin. Prolonged TSL is the major cause of maternal morbidity and mortality worldwide (12) . When the TSL is prolonged, uterine contractile abilities may decrease and blood flow from uterine vessels to the placental bed continues. Inefficient uterine contraction may lead to excessive blood loss from the placental bed and result in PPH (1, 13) . PPH is commonly defined as a blood loss of 500 mL or more within 24 hours of giving birth (14) . Although it is almost entirely a preventable condition, PPH is the most serious complication in obstetric practices, occurs in approximately 4% of vaginal deliveries, and is the major cause of maternal deaths from hemorrhage during childbearing (16) . Two thirds of PPH cases occur in women with no previously known risk factors. Thus, all pregnant women are considered to be at risk for this condition (17) . The degree of blood loss associated with placental separation and delivery depends on how quickly the placenta separates from the uterine wall and how effectively the uterine muscle contracts around the placental bed and the uterine blood vessels (3) . If the placenta is not delivered within 10 minutes, the risk of PPH increases (18) . Therefore, any intervention for shortening the duration of the TSL and preventing complications becomes important. AMTSL decreases the duration of TSL, decreases maternal blood loss, decreases the likelihood of uterine atony, and reduces the incidence of PPH by approximately 65% when compared with expectant management (1,2,3,19) . Therefore, The International Federation of Gynecologists and Obstetricians, the International Confederation of Midwives, and the World Health Organization recommend the routine use of AMTSL for all vaginal singleton births (20) .
Active management of the third stage of labor with uterotonic drugs for preventing complications during the TSL is recommended for all births (21) . Oxytocin can be administered IV or intramuscularly (IM) with fewer side effects. Prophylactic oxytocin, at any dose, decreases the development of uterine atony, PPH, and the need for therapeutic uterotonic drugs (21) . Therefore, oxytocin is universally recommended as the first-line uterotonic drug of choice for the prevention of uterine atony and related complications (8) . Additionally, oxytocin has a short half-life (3 minutes) and using oxytocin during the first and second stages of labor has no effect on TSL. Therefore, AMTSL should be recommended for all women during vaginal delivery regardless of whether they received oxytocin or not during the first and second stages of labor (2) . For this reason, in the present study, we did not regard the use of oxytocin in the first and second stages of labor.
Although oxytocin could be administrated IV/IM, the most efficient route of oxytocin administration is a slow IV infusion or a bolus infusion given over 1-2 minutes (21, 22) . Oxytocin acts quickly and effectively with minimal adverse effects and can be used in all women, which makes it the main interven- 
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tion for reducing PPH and is the first uterotonic drug option (23) . The administration of oxytocin during the TSL reduces the risk of PPH by 40% (24) . Immediately after fetal delivery, starting intravenous infusion of 20 IU of oxytocin in 500 mL RL and given within 2 hours is the routine protocol in our institute for AMTSL. This routine protocol was administered to both groups so as not to sustain any adverse effects of not using an appropriate AMTSL. This may explain why PPH or uterine atony did not develop, and the median duration of the TSL was shorter in both groups than previously reported expectant management.
It has been reported that placental cord drainage shortens the duration of TSLs. Giacalone et al. reported that in their randomized control study comparing placental cord drainage with expectant delivery of the placenta, the median TSL duration was 8 minutes in the placental cord drainage group and 15 minutes in the control group (25). Roy et al. reported that placental blood drainage during vaginal delivery shortens the duration of TSL, reduces both the blood loss and the incidence of PPH (26). Shravage et al. reported in their randomized controlled study that the average TSL duration was significantly shorter in the placental cord drainage group than in the control group (17). Sharma et al. performed a randomized study in which placental cord drainage was compared with placental cord traction during cesarean sections (10). They found that placental cord drainage shortened the TSL duration and reduced the retained placenta rate. In another study, Sharma et al. compared placental cord drainage with controlled cord traction after the administration of 0.2 mg of ergonovine with the delivery of the anterior shoulder and immediate cord clamping to compare PPH and TSL length. They reported that placental cord drainage significantly reduces the TSL duration in vaginal deliveries (11) . A 2011 Cochrane review reported that placental cord drainage significantly shortens TSL and decreases the average blood loss. The authors' concluded that there was a small reduction in the TSL length and in the amount of blood loss when cord drainage was compared with no cord drainage (27) . In the present study, placental cord drainage shortened the TSL duration. This result is in accordance with the results from previous studies.
Herman et al. ultrasonographically demonstrated that a retro-placental myometrial contraction is mandatory to produce shearing forces on the interface between the placenta and the myometrium to supply placental separation (28) . Contractions occurring prior to delivery are insufficient to cause placental separation since, in the presence of the fetus, the myometrium is unable to achieve the necessary strain for placental separation (5, 28) . Placental cord drainage is likely to decrease placental volume and surface area that might facilitate placental separation and uterine contraction, which results in a further increase of the separated area. This facilitates uterine contraction and further placental separation, resulting in early placental delivery and a shortening of the TSL duration.
This may explain why the TSL was shorter in the placental cord drainage group in the current study.
Placental retention is defined as the failure of placental delivery within 30 to 45 minutes and it usually requires intervention to assist delivery (18) . Failure of the retro-placental myometrium contraction is the usual cause of a retained placenta. When the duration of a placental retention increases to 30 minutes, there is a greater risk of PPH (5) . Placental cord drainage may facilitate uterine contractions and shorten the TSL. In the present study, there was no placental retention in the study group, and only one in the control group, which was expulsed with manual intervention under general anesthesia. This may explain why the placental retention rate was decreased in the placental cord drainage group in both the present study and previous studies.
Blood loss during TSL was not estimated in the present study. In previous studies, blood losses were estimated using difference methods. During blood collection at TSL, some amniotic fluid might enter the collection bag, or there may be an omission of blood that spattered on drapes and gowns. Thus, the measurement remains open to inaccuracies that can especially affect the measurement of lower amounts of blood loss (17) . Additionally, three guidelines from the American College of Obstetrician and Gynecologists, the Royal College of Obstetrician and Gynecologists, and the Society of Obstetricians and Gynecologists of Canada comment on the unreliability of estimated blood loss, such as using a visible estimate or through the use of blood collection drapes (8) . Instead of attempting blood collection to measure blood losses, we compared hemoglobin differences between the patient at admission and at their postpartum sixth hour. We know from previous studies that shortening the TSL duration also decreases blood loss.
The present study demonstrated that placental blood drainage with oxytocin shortened the TSL duration compared to oxytocin alone. Placental blood drainage is simple, does not introduce any additional cost, and can be performed by any birthing attendant. It might be used alone where uterotonic agents were not available or combined with oxytocin for AMTSL in low-risk vaginal deliveries. Because of the small sample size, this study is limited in its ability to derive a definitive result and generalize the results to the entire population. Furthermore, well-randomized studies with large sample sizes are needed to evaluate the effectiveness of placental cord drainage with IV oxytocin administration in the TSL.
